Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Virol Methods. Author manuscript; available in PMC 2014 February 1.
Published in final edited form as:
PMCID: PMC3556235

Susceptibility of Monkeypox virus aerosol suspensions in a rotating chamber


Viral aerosols can have a major impact on public health and on the dynamics of infection. Once aerosolized, viruses are subjected to various stress factors and their integrity and potential of infectivity can be altered. Empirical characterization is needed in order to predict more accurately the fate of these bioaerosols both for short term and long term suspension in the air. Here the susceptibility to aerosolization of the monkeypox virus (MPXV), associated with emerging zoonotic diseases, was studied using a 10.7 liter rotating chamber. This chamber was built to fit inside a Class three biological safety cabinet, specifically for studying airborne biosafety level three (BSL3) microorganisms. Airborne viruses were detected by culture and quantitative polymerase chain reaction (qPCR) after up to 90 hours of aging. Viral concentrations detected dropped by two logs for culture analysis and by one log for qPCR analysis within the first 18 hours of aging; viral concentrations were stable between 18 and 90 hours, suggesting a potential for the MPXV to retain infectivity in aerosols for more than 90 hours. The rotating chamber used in this study maintained viral particles airborne successfully for prolonged periods and could be used to study the susceptibility of other BSL3 microorganisms.

Keywords: Monkeypox virus, aerosol, bioaerosol, stability, BSL3

1. Introduction

Viral members of the Poxviridae family such as variola have been eliminated from natural circulation in the late 1970s (Fenner et al., 1988; Henderson, 1980). However, other closely related viruses, such as the monkeypox virus (MPXV), are still a threat to human health as emerging zoonotic diseases. MPXV continues to be the causative agent of sporadic enzootic outbreaks on the African continent (Di Giulio and Eckburg, 2004; Reynolds and Damon, 2012; Rimoin et al., 2010). Naïve and unvaccinated populations are becoming more susceptible to poxviral infections, as seen in a recent outbreak that occurred in the upper Midwestern United States in 2003. This limited outbreak was a result of MPXV-infected Gambian giant rats and dormice imported from the African continent that were housed with prairie dogs (CDC, 2003). Cross infection of the prairie dogs by the imported animals resulted in 35 laboratory-confirmed cases and 36 suspected or probable cases of clinical MPX. The majority of the patients had been exposed to infected prairie dogs. The incidence of MPXV in a non-endemic area such as the US heightened awareness about the population’s susceptibility to a poxviral disease such as MPX. Furthermore, this reemphasized the ongoing concern regarding the potential use of MPXV or other poxviral agents such as variola virus for nefarious purposes. Although not suspected in the importation outbreak or in naturally occurring cases, the aerosol route of exposure remains the most probable route of exposure in the case of a deliberate release of a poxvirus. To date, there is very little that is known about the susceptibility of these viruses in the aerosol environment. No empirically-derived data which details the relative susceptibility of MPXV when airborne is available to predict disease communicability better in the event of an outbreak.

Disease transmission by the aerosol route depends on the deposition of the suspect pathogen in the respiratory system of the host and on the integrity and the infectious potential of the pathogen. Empirical characterization of the infectious bioaerosol, therefore, is required in order to better understand this route of exposure. It has been postulated that variola virus, for example, can initiate infection by the inhalation of about 102 infective particles (Tucker, 2011). However, disease induction could theoretically be caused by a single infectious viral particle as long as it reaches a susceptible area of the lung. (Fenner, 1988; Nicas et al., 2004; Westwood et al., 1966). The induction of the infectious process through aerosol exposure begins with the transport of the viral-laden particles to the susceptible host and depends on the effects of physiochemical factors on the integrity of the virus (Nicas et al., 2005).

The pathogenic viruses contained in the Poxviridae family are known to remain infectious for prolonged periods of time in the environment (Essbauer et al., 2007; Wolff and Croon, 1968), yet little is known about the long term stability of these viruses in aerosols. Considering the relatively low infective dose required for disease induction with many of the pathogenic members of this viral family, it is of uttermost importance to define the potential of a virus such as the MPXV to retain its infectivity over time when airborne. This virus was selected for this study for two major reasons. The first is its hardiness which makes it a good candidate for aerosol longevity studies. The second is the public health importance of this virus and other Poxviridae.

Most studies involving prolonged exposures of particles to the airborne state are performed in rotating chambers such as described byGoldberg et al. (1958), where the competing forces exerted on the airborne particles allow a prolonged suspension period by encouraging a spiral-like motion to the particles. Although some rotating chambers set up in BSL3 laboratories are available for aerosol aging studies, the size of these chambers (Adams et al., 1982; Cutler et al., 2011; Ijaz et al., 1994; Karim et al., 1985) would require specialized equipment for safety issues. The MPXV is handled only in biosafety level three (BSL-3) laboratory environments and is highly regulated as a select biological agent by the U.S. Centers for Disease Control and Prevention (CDC) and the U.S. Department of Agriculture (USDA). The small rotating chamber described here was used inside a Class three biological safety cabinet (Class III BSC) to study the viral efficiency of MPXV and to evaluate the potential usage of the chamber for other similar pathogenic agents.

2. Methods

2.1. Aerosol chamber

A custom-built rotating chamber with a volume of 10.7 liters was used for this study. This chamber, illustrated in figure 1, placed within a standard (8’×4’×3’) Class III BSC (GermFree Laboratories, Ormond Beach, FL) which was predominantly used for animal aerosol exposures. The rotating chamber consisted of a 45.7 cm long aluminum cylinder with an interior diameter of 17.8 cm. The cylinder is closed on both ends with aluminum caps mounted on five centimeter interior diameter double-sealed ball bearings. Aluminum rods with access ports were pressure fitted in the bearings and remained stationary during rotation, which was provided by a V-Belt strapped around the chamber. The apparatus was connected to a 1/10 hp motor with speed controls. The chamber rotated on a horizontal axis at a controlled speed set between 0.8 and 1.0 rpm. The speed of rotation was selected according to the capacity of the motor and on the optimum rate of rotation as determined using equations found in Gruel et al (1987) and Asgharian and Moss (1992). A Collison three-jet nebulizer (BGI Inc., Waltham, MA) was connected to one side of the chamber and an AGI-4 sampler (model 7541), Ace Glass Inc., Vineland, NJ, USA) was connected to the other side. Capsule filters connected opposite to the sampler and to the nebulizer were used to regulate pressure in the chamber during samplings and nebulizations. All ports were controlled manually by ball valves.

Figure 1
Rotating chamber. A) Aluminum cylinder has an interior diameter of 17.8 cm, an outer diameter of 20.3 cm and is 45.7 cm long, total volume is 10.7 liters; B) end caps are composed of three pieces; a 2.5 cm thick aluminum disc (white) mounted on the outer ...

2.2. Viral strain

The MPXV (strain Zaire 79) was obtained from BEI Resources (ATCC, Manassas, VA) at a viral titer of 6.1E+08 PFU/ml. The stock virus was stored at −80°C until used in the aerosol experiments.

2.3. Aerosol production, sampling and characterization

Viral suspensions were nebulized into the chamber at 20 psi with dry HEPA-filtered compressed air. Aerosol samples were taken with AGI-4 samplers filled with 10 ml of Eagle’s Minimum Essential Media (EMEM) with penicillin and streptomycin, without fetal bovine serum (FBS) and supplemented with 25µl of antifoam A and then operated at sonic velocity at 6 L/min. For every sample, a five minute nebulization was followed by a two minute aging period (for C0 and G0) with all ports of the chamber sealed and a 10 minute air sampling period; this is the initial nebulization sample. The same aliquot of viral suspension was then used for a second five minute nebulization followed by an aerosol aging period ranging from two minutes to 90 hours (for Caged and Gaged). Each time point was done in triplicate. The air from the chamber was flushed with 100 L of dry filtered air (10 L/min for 10 minutes) between each iteration of the nebulization. Negative control (n=2) samples were collected after the 100 l air flush. All aerosol samples and remaining liquid samples from nebulizers were placed at −80°C until analysis by plaque assay and quantitative PCR (qPCR). Relative humidity and temperature inside the rotating chamber were recorded every five minutes with a thermocouple probe (model RH-USB, Omega Engineering, Inc., Stamford, CT, USA). Particle size distribution was determined at zero and 18 hour time points with aerosols of sterile media and during nebulization of MPXV with an aerodynamic particle sizer (APS; model 3321, TSI Inc., Shoreview, MN).

2.4. Plaque assays

Plaque assays were performed on Vero E6 cells (ATCC number CRL-1586) grown to 95% confluency in complete EMEM (EMEM/NEAA; Sigma) supplemented with 2% FBS, penicillin (four units/mL), streptomycin (four µg/mL), gentamicin (20 µg/mL) and fungizone (0.1 µg/mL). Six-well plates were inoculated in triplicate as described byNalca et al. (2010) with 100 µl of serially-diluted samples and incubated with two ml of complete media for 96 hours at 37°C with 5% CO2. After incubation, media was removed and two ml of 0.1% crystal violet solution were added to each well. Stain solution was removed after one hour at room temperature and rinsed with tap water. Plates were placed upside down overnight for drying and plaques were counted the next day. Tissue culture infective viral concentrations were expressed as plaque forming units per liter of air assuming the entire 10.7 liters of air from the chamber was collected into the AGI media (pfu/L of air). The efficiency of the virus in aerosol was determined by dividing the value obtained after aging (Caged) by the value obtained after the initial nebulization (C0). This resulted in a fraction of remaining infective viruses in the aerosol which can account for day to day variations and allows better comparisons of samples.

2.5. Quantitative polymerase chain reaction

Viral DNA was purified from 200 µl of undiluted aerosol with the High Pure Viral Nucleic Acid kit (Roche Applied Science, Indianapolis, IN) according to the manufacturer’s protocol. MPXV genome concentrations were then quantified in duplicates by qPCR using the primers, probe and standard curve described previously (Verreault et al., 2012). Viral concentrations were expressed as number of MPXV genomes per liter of air. The aerosol viral efficiency by qPCR was calculated in the same way (Gaged/G0) as for culture results.

2.6. Statistical analysis

Statistical analysis was performed with the SigmaPlot software (Systat Software, Inc., Version 11.2, San Jose, CA). Viral concentrations and fractions of remaining virus expressed as PFU or genomes were compared by one way analysis of variance (ANOVA). All pairwise multiple comparison procedures were done with the Holm-Sidak method. Differences between the proportions of infective viruses (PFU/genomes) were compared by t-test between time points. Differences were considered significant at p<0.05.

3. Results

3.1. Environmental conditions and aerosol characteristics

Chamber temperature remained stable at 20–22°C across all aging assays. Relative humidity (RH) inside the chamber reached 97% and decreased by about 0.4% per hour during the aging periods. The RH remained high (60–97%) during all assays. APS data, illustrated in figure 2, indicated a mass median aerodynamic diameter (MMAD; figure 2 A) of 4.0 µm with a geometric standard deviation (σg) of 2.0 immediately after nebulization of sterile media, and a MMAD of 1.6 µm with a σg of 2.7 after 18 hours of aging; MPXV aerosols had a MMAD of 4.1 µm during nebulization. The count median aerodynamic diameter (CMAD) illustrated in figure 2 B shows the distribution of the same samples of airborne particles by count rather than by total weight; the CMAD was 1.3 µm initially and 1.0 after 18 hours of aging.

Figure 2
Aerodynamic distribution of airborne particles inside the rotating chamber after nebulization of sterile media with a Collison three-jet nebulizer. Samples (20s) were taken with the APS immediately after nebulization was stopped (dashed line) and after ...

3.2. Quantitative PCR and plaque assay analysis

Quantitative PCR and plaque assay analysis revealed detectable concentrations of viral genomes and infective viruses throughout the experiment. As seen in figure 3, mean genome concentrations in the chamber were 1.2E+07 ± 7.9E+06 genomes per liter of air after two minutes and 2.6E+05 ± 1.5E+05 genomes/l air after 90 hours of aging. Viral concentrations dropped rapidly (one log) within the first 18 hours of aging and stabilized between 18 and 90 hours. Plaque assay analysis of the aerosol samples revealed a two log decrease within the first 18 hours followed by a stabilization of the concentration (figure 3; empty circles). The initial loss of larger particles was confirmed by the APS data (figure 2).

Figure 3
Aerosol sample analysis by qPCR (full circles) and by plaque assay (white circles). Decay rate is rapid in the first hours and slows down with time. Error bars are standard deviations. Significant differences (One way ANOVA, Holm-Sidak method; P<0.05) ...

The portion of viral genomes associated with PFU was calculated by the ratio of PFU to genomes in each aerosol sample (figure 4). No significant difference was observed between two and 30 minutes of aging. A ten-fold decrease in the proportion of infective particles was observed after three hours. This decrease was significant (P<0.05) after three, 18, 48 and 90 hours when compared to the initial portion of infective viruses at two minutes. There was no significant difference between 30 minutes, three hours, 18, 48 and 90 hours.

Figure 4
Proportion of genomes detected associated with infective viral particles enumerated by plaque assay. Asterisk (*) indicates a significant difference as opposed to the samples taken at 0.03 hours (t-test; P<0.05). There is no significant difference ...

The remaining fractions of MPXV were determined by comparing the initial viral concentration after two minutes of aging to the concentration observed after the aging period of two minutes to 90 hours. The results show a significant decrease in MPXV concentration after three hours by qPCR analysis (Figure 5 A) and after 18 hours by plaque assay analysis (Figure 5 B).

Figure 5
Aerosol sample analysis by qPCR (A; full circles) and plaque assay (B; white circles). The concentration of the aged aerosol in genomes per liter of air (Gaged), or in pfu per liter of air (Caged), was divided by the concentrations detected after the ...

4. Discussion

Although the physical decay rate of a polydispersed aerosol in a static chamber is relatively well understood and can be estimated using known constants such as terminal settling velocity (Hinds, 1999), actual suspension time in uncontrolled settings is less predictable due to highly variable environmental conditions. Biological aerosols are known to be generally hygroscopic (Ariya et al., 2009), rendering a higher susceptibility to variations in relative humidity and temperature. This can dramatically affect the physical dynamics of the aerosol, as well as the integrity of airborne viral particles and their potential to initiate infection once introduced in the host respiratory system. Modeling transport in a chamber that overcomes terminal settling velocity allows experimental observation of the effects of the constellation of physical and biological stressors when in aerosol. Rotating chambers have been used before to study aging viral aerosols (Adams et al., 1982; Akers et al., 1973; Elazhary and Derbyshire, 1979a, 1979b, 1979c; Harper, 1961; Ijaz et al., 1985, 1994; Karim et al., 1985; Sattar et al., 1984; Songer, 1967;Webb et al., 1963); however, the large size of the chambers used in these studies render their use in standard biosafety cabinets impractical or impossible. The results from this study show that a small 10.7 liter rotating chamber which can easily be set up in standard Class three biosafety cabinets can be used to study the long term efficiency of airborne viral pathogens.

Infective viruses were recovered from suspended aerosols after 90 hours of aging in the rotating chamber. Figure 3 illustrates how the concentrations of total and infective MPXV tended to stabilize between 18 and 90 hours; this suggests that viral particles could have been detected beyond 90 hours of aging.

The rapid initial loss of viral genomes could be explained by the deposition of larger particles on the chamber’s wall. Although the airborne particles in the rotating chamber are submitted to both centrifugal and gravitational forces (Asgharian and Moss, 1992), the larger particles remain more affected by gravity and settle more rapidly than the smaller particles. Another possible explanation for the initial loss, in regards to infectivity, could be the harsh conditions to which the viral suspension is subjected to during nebulization. The strong shearing forces exerted on the nebulization liquid in the Collison are known to affect the cultivability of bacteria (Stone and Johnson, 2002). These forces could also affect viral integrity thus lowering the number of infective viruses and lowering the preservation of infectivity in the airborne state. However, these same conditions could also increase the number of PFU detected by breaking up clumps of aggregated viruses. This phenomenon could explain the high fractions of PFU detected after two minutes of aging as illustrated in figure 5 B.

The damaged viral particles would also become more sensitive to the sampling process. Although aerosol sampling by liquid impingement is relatively gentle when compared to other sampling methods (Verreault et al., 2008), it is likely that some viral particles were inactivated during sampling. The aerosol stability of MPXV infectivity could thus have been underestimated. Less aggressive methods of aerosolization may minimize this effect by reducing the damages to the viral particles. The aerosol efficiency of viruses should ideally be studied from aerosols produced naturally by the shedding of infected hosts or from secondary aerosolization produced from infected matter. The high variability associated with viral production from these sources unfortunately makes the studying of naturally-generated viral bioaerosols exceedingly difficult.

Another problem encountered when studying the aerosol stability of viruses is the rapid loss of the larger particles due to the effect of gravity; this effect can also be observed when using rotating chambers. In order to minimize this loss over time, it is possible to mimic aerosol suspension of viruses and to study their stability in various environmental conditions by using a physical support, such as spider webs (Smither et al., 2011), to retain the viral-laden particles in conditions very similar to the aerosol environment. This would prevent the physical loss of larger particles due to gravity. However, the viral particles still need to be nebulized and are thus subjected to potentially destructive physical stress. Although no single method is ideal, the tools and techniques available for studying airborne microorganisms, when used conjointly, could help answer important questions regarding the stability and potential hazards associated to these microorganisms.

The longevity of the MPXV in a laboratory controlled aerosol state suggests that this virus could potentially remain infectious for long periods of time in the environment. The most uncharacterized route of exposure during epidemics remains to be the aerosol route of transmission. Respiratory protection in conjunction with prophylactic medical intervention such as ring vaccination is part of the precautions taken when facing such an outbreak. A better understanding of the fate of airborne viruses or other infectious agents greatly improves our response to such events by extension of the informational database of susceptibility for viruses that can be transmitted by the aerosol route and are important to human health.


  • We characterize the viral susceptibility of monkeypox (MPX) virus when in aerosol form.
  • Susceptibility studies over time were performed using a small rotating drum in a class III BSC.
  • MPX is resistant to degradation when in aerosol, remaining viable in suspension for up to 90 hours.


This research was supported in part by (base grant). We thank Anthony Jensen from mechanical services at Tulane University for his technical support in building the rotating chamber.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


  • Adams DJ, Spendlove JC, Spendlove RS, Barnett BB. Aerosol stability of infectious and potentially infectious reovirus particles. Appl. Environ. Microbiol. 1982;44:903–908. [PMC free article] [PubMed]
  • Akers TG, Prato CM, Dubovi EJ. Airborne stability of simian virus 40. Appl. Microbiol. 1973;26:146–148. [PMC free article] [PubMed]
  • Ariya PA, Sun J, Eltouny NA, Hudson ED, Hayes CT, Kos G. Physical and chemical characterization of bioaerosols - Implications for nucleation processes. Int. Rev. Phys. Chem. 2009;28:1–32.
  • Asgharian B, Moss OR. Particle suspension in a rotating drum chamber when the influence of gravity and rotation are both significant. Aerosol Sci. Tech. 1992;17:263–277.
  • Centers for Disease Control and Prevention (CDC) Update: multistate outbreak of monkeypox--Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb. Mortal. Wkly Rep. 2003;52:642–646. [PubMed]
  • Cutler TD, Wang C, Hoff SJ, Kittawornrat A, Zimmerman JJ. Median infectious dose (ID(50)) of porcine reproductive and respiratory syndrome virus isolate MN-184 via aerosol exposure. Vet. Microbiol. 2011;151:229–237. [PubMed]
  • Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect. Dis. 2004;4:15–25. [PubMed]
  • Elazhary MA, Derbyshire JB. Aerosol stability of bovine adenovirus type 3. Can. J. Comp. Med. 1979a;43:305–312. [PMC free article] [PubMed]
  • Elazhary MA, Derbyshire JB. Aerosol stability of bovine parainfluenza type 3 virus. Can. J. Comp. Med. 1979b;43:295–304. [PMC free article] [PubMed]
  • Elazhary MA, Derbyshire JB. Effect of temperature, relative humidity and medium on the aerosol stability of infectious bovine rhinotracheitis virus. Can. J. Comp. Med. 1979c;43:158–167. [PMC free article] [PubMed]
  • Essbauer S, Meyer H, Porsch-Ozcurumez M, Pfeffer M. Long-lasting stability of vaccinia virus (orthopoxvirus) in food and environmental samples. Zoonoses Public Health. 2007;54:118–124. [PubMed]
  • Fenner F. Smallpox and its eradication. Geneva: WHO; 1988.
  • Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: WHO; 1988.
  • Goldberg LJ, Watkins HM, Boerke EE, Chatigny MA. The use of a rotating drum for the study of aerosols over extended periods of time. Am. J. Hyg. 1958;68:85–93. [PubMed]
  • Gruel RL, Reid CR, Allemann RT. The optimum rate of drum rotation for aerosol aging. J. Aerosol Sci. 1987;18:17–22.
  • Harper GJ. Airborne microorganisms: survival tests with four viruses. J. Hyg. (Lond.) 1961;59:479–486. [PMC free article] [PubMed]
  • Henderson DA. Smallpox eradication. Public Health Rep. 1980;95:422–426. [PMC free article] [PubMed]
  • Hinds WC. Aerosol technology. 2 ed. Wiley-Interscience; 1999.
  • Ijaz MK, Sattar SA, Alkarmi T, Dar FK, Bhatti AR, Elhag KM. Studies on the survival of aerosolized bovine rotavirus (UK) and a murine rotavirus. Comp. Immunol. Microbiol. Infect. Dis. 1994;17:91–98. [PubMed]
  • Ijaz MK, Sattar SA, Johnson-Lussenburg CM, Springthorpe VS, Nair RC. Effect of relative humidity, atmospheric temperature, and suspending medium on the airborne survival of human rotavirus. Can. J. Microbiol. 1985;31:681–685. [PubMed]
  • Karim YG, Ijaz MK, Sattar SA, Johnson-Lussenburg CM. Effect of relative humidity on the airborne survival of rhinovirus-14. Can. J. Microbiol. 1985;31:1058–1061. [PubMed]
  • Nalca A, Livingston VA, Garza NL, Zumbrun EE, Frick OM, Chapman JL, Hartings JM. Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus. PLoS One. 2010;5:e12880. [PMC free article] [PubMed]
  • Nicas M, Hubbard AE, Jones RM, Reingold AL. The infectious dose of variola (smallpox) virus. Applied Biosafety. 2004;9:118–127.
  • Nicas M, Nazaroff WW, Hubbard A. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J. Occup. Environ. Hyg. 2005;2:143–154. [PubMed]
  • Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 2012;20:80–87. [PubMed]
  • Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, Blumberg S, Thomassen HA, Pike BL, Fair JN, Wolfe ND, Shongo RL, Graham BS, Formenty P, Okitolonda E, Hensley LE, Meyer H, Wright LL, Muyembe JJ. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. USA. 2010;107:16262–16267. [PubMed]
  • Sattar SA, Ijaz MK, Johnson-Lussenburg CM, Springthorpe VS. Effect of relative humidity on the airborne survival of rotavirus SA11. Appl. Environ. Microbiol. 1984;47:879–881. [PMC free article] [PubMed]
  • Smither SJ, Piercy TJ, Eastaugh L, Steward JA, Lever MS. An alternative method of measuring aerosol survival using spiders' webs and its use for the filoviruses. J. Virol. Methods. 2011;177:123–127. [PubMed]
  • Songer JR. Influence of relative humidity on the survival of some airborne viruses. Appl. Microbiol. 1967;15:35–42. [PMC free article] [PubMed]
  • Stone RC, Johnson DL. A note on the effect of nebulization time and pressure on the culturability of Bacillus subtilis and Pseudomonas fluorescens. Aerosol Sci. Tech. 2002;36:536–539.
  • Tucker JB. Breaking the deadlock over destruction of the smallpox virus stocks. Biosecur. Bioterror. 2011;9:56–67. [PubMed]
  • Verreault D, Moineau S, Duchaine C. Methods for sampling of airborne viruses. Microbiol. Mol. Biol. Rev. 2008;72:413–444. [PMC free article] [PubMed]
  • Verreault D, Sivasubramani SK, Talton JD, Doyle LA, Reddy JD, Killeen SZ, Didier PJ, Marx PA, Roy CJ. Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model. Antiviral Res. 2012;93:204–208. [PMC free article] [PubMed]
  • Webb SJ, Bather R, Hodges RW. The effect of relative humidity and inositol on air- borne viruses. Can. J. Microbiol. 1963;9:87–92.
  • Westwood JC, Boulter EA, Bowen ET, Maber HB. Experimental respiratory infection with poxvirusesIClinical virological and epidemiological studies. Br. J. Exp. Pathol. 1966;47:453–465. [PubMed]
  • Wolff HL, Croon JJ. The survival of smallpox virus (variola minor) in natural circumstances. Bull. World Health Organ. 1968;38:492–493. [PubMed]